Dr. Scott Friedman, the Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai

Om avsnittet

Causes of chronic liver diseases, emerging treatments, COVID-19

Dr. Scott Friedman is the Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases, at the Icahn School of Medicine at Mount Sinai. He has performed pioneering research into the underlying causes of scarring, or fibrosis associated with chronic liver disease, affecting millions worldwide. His work has spawned an entire field that is now realizing its translational and therapeutic potential, with new anti-fibrotic therapies for liver disease reaching clinical trials.

Om avsnittet

Fler avsnitt

Prof. Alex Chan of Harvard on Explainable AI, Medical liability of AI, and the collapse of WWW.

Prof. Zaldy Tan of UCLA on What to Remember When You Are Forgetting

Prof. Mark Mattson of Johns Hopkins on metabolic switching and intermittent fasting

Prof. Rachael Brown of the University of Chicago on Christians and Christianity

Prof. Trevor Robbins of Univ. of Cambridge on the neural basis of compulsive disorders

Prof. Eric Betzig of Univ. of California, Berkely on high resolution imaging of biological systems

Prof. Emil Martinec of the University of Chicago on String theory & black holes information paradox

Prof. Jonathan Silvertown of the Univ. of Edinburgh on how leaves conjure up the world

Prof. Stephanie Schmitt-Grohe of Columbia University on the Neo-Fisher Effect in Monetary Policy

Prof. Mariassunta Giannetti on supply chains, market power, inflation and liquidity reallocation